Please login to the form below

Not currently logged in
Email:
Password:

Teva to use cloud-based CRM for sales force

Picks Veeva’s system to streamline operations
Teva Pharma

Teva Pharmaceuticals is to introduce a cloud-based customer relationship management (CRM) solution for many of its commercial teams in order to streamline operations and improve global collaboration.

Teva is replacing its current methods across 45 markets worldwide with a CRM system from Veeva.

This CRM tool is already deployed across Teva's US field teams and is now being rolled out in Europe. It is expected to be introduced across other Teva regions over the coming months.

"By leveraging Veeva as a single system, we will increase efficiency and improve customer engagement," said Teva global chief information officer Guy Hadari, who also commented on the system's ability to support integrated multichannel marketing.

According to Hadri, the CRM allows Teva “to capture valuable customer insights about channel preferences and content needs”

He added: “It also increases efficiency by connecting commercial teams and regions that had been highly fragmented."

Teva has a legacy of working in generic pharmaceuticals but has increased its interest in branded products, meaning it needed a CRM system capable of supporting both commercial models.

"It is an honour to partner with Teva on this important transformation," said Veeva CEO Peter Gassner.

Teva's adoption of the new system is just the latest example of pharma embracing a multichannel approach to marketing.

According to Veeva vice president commercial strategy Jan van den Burg, '2014 marks the year where most healthcare professionals are now 'digital natives'', meaning that they have grown up with digital technology as an integrated part of communications.

Article by
Tara Craig

4th June 2014

From: Sales

Share

Tags

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Dovetail

We’re a specialist health consultancy that supports companies, healthcare professionals and patients to work hand in hand with a common...

Latest intelligence

Why big pharma needs to be braver
The last few years have seen the pharmaceutical industry undergo a rapid metamorphosis in the face of unprecedented change, but communications are one area that still needs an injection of...
Leveraging Real-World Evidence for Cell and Gene Therapies
Regulators and reimbursement bodies are increasingly turning to real-world evidence (RWE) to understand the long-term value of drugs, in particular novel therapies. Here, Mariam Bibi, Senior Director, Global RWE at...
Food Allergy – Is avoidance the only option?
Following on from Allergy Awareness Week 2022, we’re continuing the discussion about food allergies and the experiences of those who live with them. In this blog, we discuss the current...